Literature DB >> 26225681

Predictors of Participation in Prostate Cancer Screening among Older Men in Jordan.

Mohammad H Abuadas1, Wasileh Petro-Nustas, Zainab F Albikawi.   

Abstract

BACKGROUND: Participation is one of the major factors affecting the long-term success of population-based prostate cancer screening programs. The aim of this study was to explore strong factors linked to participation in prostate cancer screening among older Jordanian adults using the Health Belief Model (HBM).
MATERIALS AND METHODS: Data were obtained from Jordanian older adults, aged 40 years and over, who visited a comprehensive health care center within the Ministry of Health. A pilot test was conducted to investigate the internal consistency of the the Champion Health Belief Model Scale for prostate cancer screening and the clarity of survey questions. Sample characteristics and rates of participation in prostate cancer screening were examined using means and frequencies. Important factors associated with participation in prostate cancer screening were examined using bivariate correlation and multivariate logistic regression analysis.
RESULTS: About 13% of the respondents had adhered to prostate cancer screening guidelines over the previous decade. Four out of the seven HBM-driven factors (perceived susceptibility, benefits and barriers to PSA test, and health motivation) were statistically significant. Those with greater levels of susceptibility, benefits of PSA test and health motivation and lower levels of barriers to PSA testing were more likely to participate in prostate cancer screening. Family history, presence of urinary symptoms, age, and knowledge about prostate cancer significantly predicted the participation in prostate cancer screening.
CONCLUSIONS: Health professionals should focus more on the four modifiable HBM-related factors to encourage older adults to participate in prostate cancer screening. Intervention programs, which lower perceived barriers to PSA testing and increase susceptibility, benefits of PSA testing and health motivation, should be developed and implemented.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26225681     DOI: 10.7314/apjcp.2015.16.13.5377

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

Review 1.  What's new in screening in 2015?

Authors:  Sigrid V Carlsson; Monique J Roobol
Journal:  Curr Opin Urol       Date:  2016-09       Impact factor: 2.309

2.  Characteristics and attitudes of first round invitees in the Irish National Colorectal Cancer Screening Programme.

Authors:  Susanne M O'Reilly; Katie N Hughes; Therese Mooney; Patricia Fitzpatrick; Diarmuid O'Donoghue; Sara McNally; Mary Codd; Elizabeth Ryan; Glen Doherty; Olivia Mason; Hugh E Mulcahy; Garret Cullen
Journal:  Frontline Gastroenterol       Date:  2020-06-10

3.  The association between the knowledge on prostate cancer screening with the beliefs and behaviors of Saudi men attending King Khalid University Hospital.

Authors:  Sulaiman Alshammari; Raed Alojayri; Muaath AlJehani; Faisal Almuhid; Omar Alotaibi; Mohammed Alqahtani; Abdulaziz AlGhamdi
Journal:  J Family Med Prim Care       Date:  2021-12-27

4.  Effect of Perceived Self-Vulnerability on Prostate Cancer Screening Uptake and Associated Factors: A Cross-Sectional Study of Public Health Facilities in Western Kenya.

Authors:  Charles Oduor Opondo; Patrick Ogola Onyango; Collins Otieno Asweto
Journal:  Ann Glob Health       Date:  2022-02-17       Impact factor: 2.462

5.  Early Detection of Prostate Cancer: Self-Reported Knowledge and Attitude of Physicians in Jordan.

Authors:  Mohammad A Y Alqudah; Raneem Al-Samman; Obada Matalgah; Rana Abu Farhah
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

6.  Maturity Level of the Stigma Concept Associated with Cancer Diagnosis in the Nursing Literature

Authors:  Muayyad M Ahmad; Ruba Musallam; Abla Habeeb Allah; Laila Al-Daken; Hana Abu-Snieneh; Ghadeer Al-Dweik
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.